Filing Details
- Accession Number:
- 0001209191-20-050683
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 16:02:18
- Reporting Period:
- 2020-09-14
- Accepted Time:
- 2020-09-16 16:02:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1748177 | Bahram Valamehr | C/O Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-14 | 3,076 | $1.69 | 90,287 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-09-14 | 21,924 | $2.90 | 112,211 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-14 | 600 | $34.65 | 111,611 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-14 | 16,784 | $36.03 | 94,827 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-14 | 7,016 | $36.93 | 87,811 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-14 | 600 | $37.49 | 87,211 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-09-14 | 3,076 | $0.00 | 3,076 | $1.69 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-09-14 | 21,924 | $0.00 | 21,924 | $2.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-03-11 | No | 4 | M | Direct | |
66,156 | 2026-01-07 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020.
- Represents the weighted average sale price of the shares sold ranging from $34.26 to $35.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $35.47 to $36.46 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $36.47 to $37.45 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $37.47 to $37.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- This option is fully vested.
- Not applicable.